Platform
Features
0 followers
Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.
Industries
Headquarters
Employees
Links
Randall B Riggs
6 members
5 members
GRAIL
27 followers
Cytokinetics
11 followers
BridgeBio
2 followers
Neogene Therapeutics
Merck
199 followers
Included Health
25 followers
Schweiger Dermatology
1 follower
Thermo Fisher Scientific
147 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
Discover companies
